74 related articles for article (PubMed ID: 17663985)
21. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
[TBL] [Abstract][Full Text] [Related]
22. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
Wingate PJ; McAulay KA; Anthony IC; Crawford DH
J Med Virol; 2009 May; 81(5):870-7. PubMed ID: 19319950
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy with virus-specific cytotoxic T lymphocytes after organ transplantation.
Lucas KG; Sun Q
Pediatr Transplant; 2006 Mar; 10(2):142-4. PubMed ID: 16573596
[TBL] [Abstract][Full Text] [Related]
24. Phenotype and functional evaluation of ex vivo generated antigen-specific immune effector cells with potential for therapeutic applications.
Han S; Huang Y; Liang Y; Ho Y; Wang Y; Chang LJ
J Hematol Oncol; 2009 Aug; 2():34. PubMed ID: 19660111
[TBL] [Abstract][Full Text] [Related]
25. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
26. IL-21 synergizes with IL-7 to augment expansion and anti-tumor function of cytotoxic T cells.
Liu S; Lizée G; Lou Y; Liu C; Overwijk WW; Wang G; Hwu P
Int Immunol; 2007 Oct; 19(10):1213-21. PubMed ID: 17898044
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-targeted immunotherapy for nasopharyngeal carcinoma.
Masmoudi A; Toumi N; Khanfir A; Kallel-Slimi L; Daoud J; Karray H; Frikha M
Cancer Treat Rev; 2007 Oct; 33(6):499-505. PubMed ID: 17544585
[TBL] [Abstract][Full Text] [Related]
28. Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNA.
Hofmann C; Harrer T; Kubesch V; Maurer K; Metzner KJ; Eismann K; Bergmann S; Schmitt-Haendle M; Schuler G; Dörrie J; Schaft N
AIDS; 2008 Aug; 22(13):1577-82. PubMed ID: 18670216
[TBL] [Abstract][Full Text] [Related]
29. In vitro methods for generating highly purified EBV associated tumor antigen-specific T cells by using solid phase T cell selection system for immunotherapy.
Li J; Mookerjee B; Wagner J; Flomenberg N
J Immunol Methods; 2007 Dec; 328(1-2):169-81. PubMed ID: 17931649
[TBL] [Abstract][Full Text] [Related]
30. Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.
Kondo T; Takata H; Matsuki F; Takiguchi M
J Immunol; 2009 Feb; 182(4):1794-8. PubMed ID: 19201830
[TBL] [Abstract][Full Text] [Related]
31. [Dendritic cells transfected with recombinant adenovirus Ad5F35-LMP2 induces LMP2 specific immunity mediated by cytotoxic T lymphocytes in vitro].
Mo WN; Zhou L; Wang Z; Tang AZ; Huang GW; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):254-6. PubMed ID: 19105335
[TBL] [Abstract][Full Text] [Related]
32. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
[TBL] [Abstract][Full Text] [Related]
33. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.
Iancu EM; Corthesy P; Baumgaertner P; Devevre E; Voelter V; Romero P; Speiser DE; Rufer N
J Immunol; 2009 Jul; 183(1):319-31. PubMed ID: 19542443
[TBL] [Abstract][Full Text] [Related]
34. Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression.
Wehler TC; Karg M; Distler E; Konur A; Nonn M; Meyer RG; Huber C; Hartwig UF; Herr W
J Immunol Methods; 2008 Nov; 339(1):23-37. PubMed ID: 18760281
[TBL] [Abstract][Full Text] [Related]
35. [In vitro induced and expanded Epstein Barr virus-specific cytotoxic T lymphocytes can specifically kill nasopharyngeal carcinoma cells].
Chen LP; Huang JQ; Zhou TC; Zhang SX; Wang JL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1431-3. PubMed ID: 18753079
[TBL] [Abstract][Full Text] [Related]
36. IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.
Thedrez A; Harly C; Morice A; Salot S; Bonneville M; Scotet E
J Immunol; 2009 Mar; 182(6):3423-31. PubMed ID: 19265120
[TBL] [Abstract][Full Text] [Related]
37. Cytokine maturation followed by CD40L mRNA electroporation results in a clinically relevant dendritic cell product capable of inducing a potent proinflammatory CTL response.
Calderhead DM; DeBenedette MA; Ketteringham H; Gamble AH; Horvatinovich JM; Tcherepanova IY; Nicolette CA; Healey DG
J Immunother; 2008 Oct; 31(8):731-41. PubMed ID: 18779746
[TBL] [Abstract][Full Text] [Related]
38. CMV-specific TCR-transgenic T cells for immunotherapy.
Schub A; Schuster IG; Hammerschmidt W; Moosmann A
J Immunol; 2009 Nov; 183(10):6819-30. PubMed ID: 19864595
[TBL] [Abstract][Full Text] [Related]
39. Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy.
Besser MJ; Schallmach E; Oved K; Treves AJ; Markel G; Reiter Y; Schachter J
Cytotherapy; 2009; 11(2):206-17. PubMed ID: 19148842
[TBL] [Abstract][Full Text] [Related]
40. Correlation of effector function with phenotype and cell division after in vitro differentiation of naive MART-1-specific CD8+ T cells.
Casado JG; DelaRosa O; Pawelec G; Peralbo E; Duran E; Barahona F; Solana R; Tarazona R
Int Immunol; 2009 Jan; 21(1):53-62. PubMed ID: 19050104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]